Event Type
Disclosure
Mandatory
Variant
8-K
. Entry into a Material Definitive Agreement On March 3, 2026 (the “Effective Date”), Genevant Sciences GmbH (“Genevant”), a subsidiary of Roivant Sciences Ltd.
, including Exhibit 99.1, shall not be deemed incorporated by reference into any other filing with the SEC made by the Company, whether made before or after the
. Other Information On March 3, 2026, Roivant’s board of directors authorized an increase in the size of the previously approved common share repurchase program
. Financial Statements and Exhibits (d) Exhibits. Exhibit No. Description of Exhibit 99.1 Press Release, dated March 3, 2026. 104 C over Page Interactive Data F